Clinical indicators for recurrent cardiovascular events in acute coronary syndrome patients treated with statins under routine practice in Thailand: an observational study

Table 3 Univariable and multivariable analysis of clinical indicators for recurrent cardiovascular events (n = 405)

Clinical indicators	OR (95 % CI)	p-value	Multivariable OR (95 % CI)	p-value
LDL-C goal attainment
LDL-C ≥ 100 mg/dL	1.00		1.00
LDL-C 70–99 mg/dL	0.75 (0.36–1.58)	0.448	0.67 (0.35–1.30)	0.240
LDL-C < 70 mg/dL	0.55 (0.33–0.91)	0.019	0.43 (0.27–0.69)	<0.001
Revascularization	0.32 (0.17–0.63)	0.001	0.44 (0.24–0.81)	0.009
eGFR < 60 mL/min/1.73 m²	3.24 (2.74–3.82)	<0.001	2.46 (2.21–2.75)	<0.001
Male gender	1.25 (0.79–1.96)	0.337	1.85 (1.29–2.66)	0.001
Age (year)	1.03 (1.01–1.04)	<0.001	1.00 (0.99–1.03)	0.258
Hypertension	2.39 (1.20–4.73)	0.013	1.66 (0.70–3.95)	0.249
ACEI/ARB	0.53 (0.35–0.81)	0.003	0.72 (0.49–1.06)	0.101
Diabetes mellitus	2.09 (0.67–6.50)	0.202	1.56 (0.52–4.73)	0.428
Follow-up time (day)^a	1.00 (1.00–1.00)	0.908	1.00 (1.00–1.00)	0.890

Abbreviations: OR, odds ratio; CI, confidence interval; LDL-C, low-density lipoprotein cholesterol; mg/dL, milligrams per deciliter; eGFR, estimated glomerular filtration rate; ACEI/ARB, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers
Note:^atime from index hospitalization to the last medical contact

ISSN: 1471-2261